162 related articles for article (PubMed ID: 35267621)
1. Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV.
Gerard JP; Myint AS; Barbet N; Dejean C; Thamphya B; Gal J; Montagne L; Vuong T
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267621
[TBL] [Abstract][Full Text] [Related]
2. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP
Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.
Gerard JP; Barbet N; Schiappa R; Magné N; Martel I; Mineur L; Deberne M; Zilli T; Dhadda A; Myint AS;
Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):356-367. PubMed ID: 36801007
[TBL] [Abstract][Full Text] [Related]
4. Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence.
Benezery K; Montagne L; Evesque L; Schiappa R; Hannoun-Levi JM; Francois E; Thamphya B; Gerard JP
Clin Transl Radiat Oncol; 2020 Sep; 24():92-98. PubMed ID: 32695890
[TBL] [Abstract][Full Text] [Related]
5. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
Sun Myint A; Rao C; Barbet N; Thamphya B; Pace-Loscos T; Schiappa R; Magné N; Martel-Lafay I; Mineur L; Deberne M; Zilli T; Dhadda A; Gerard JP
Colorectal Dis; 2023 Nov; 25(11):2160-2169. PubMed ID: 37837240
[TBL] [Abstract][Full Text] [Related]
7. Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
Sun Myint A; Smith FM; Gollins S; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman M; Pritchard DM
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):565-573. PubMed ID: 29229327
[TBL] [Abstract][Full Text] [Related]
8. Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis.
Steinke J; Jordan C; Rossides S; Minnaar H; Yu J; Franklin A; Rockall T; Dhadda AS; Andrew Hunter I; Mills J; Chadwick E; Silverman R; Folkesson J; Radu C; Myint AS; Stewart AJ
Clin Transl Radiat Oncol; 2023 Mar; 39():100580. PubMed ID: 36686563
[TBL] [Abstract][Full Text] [Related]
9. Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer.
Gerard JP; Montagne L; Thamphya B; Doyen J; Schiappa R; Benezery K; Gourgou S; Dejean C; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Mar; 33():70-76. PubMed ID: 35118202
[TBL] [Abstract][Full Text] [Related]
10. Low energy contact X-ray brachytherapy for treatment of rectal cancer: a health technology appraisal by Health Technology Wales.
Bennett H; Rao C; Batten L; Hasler E; Jarrom D; Prettyjohns M; Barrington C; Sun Myint A
Colorectal Dis; 2024 May; 26(5):1053-1058. PubMed ID: 38467574
[TBL] [Abstract][Full Text] [Related]
11. A multi-centre analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision - Preliminary results of the CONTEM1 study.
Dhadda A; Sun Myint A; Thamphya B; Hunter I; Hershman M; Gerard JP
Radiother Oncol; 2021 Sep; 162():195-201. PubMed ID: 34329654
[TBL] [Abstract][Full Text] [Related]
12. Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?
Sun Myint A; Smith FM; Gollins SW; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman MJ; Fekete Z; Perkins K; Pritchard DM
Br J Radiol; 2017 Dec; 90(1080):20170175. PubMed ID: 28937269
[TBL] [Abstract][Full Text] [Related]
13. GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer.
Stewart AJ; Van Limbergen EJ; Gerard JP; Appelt AL; Verhaegen F; Berbee M; Vuong T; Brooker C; Rockall T; Sun Myint A
Clin Transl Radiat Oncol; 2022 Mar; 33():15-22. PubMed ID: 35243017
[TBL] [Abstract][Full Text] [Related]
14. Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.
Ortholan C; Romestaing P; Chapet O; Gerard JP
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e165-71. PubMed ID: 22579379
[TBL] [Abstract][Full Text] [Related]
15. Contact X-ray brachytherapy (CXB) as a salvage treatment for rectal cancer patients who developed local tumor re-growth after watch-and-wait approach.
Than NW; Pritchard DM; Duckworth CA; Hughes DM; Wong H; Sripadam R; Myint AS
J Contemp Brachytherapy; 2024 Apr; 16(2):95-102. PubMed ID: 38808203
[TBL] [Abstract][Full Text] [Related]
16. Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone.
Gerard JP; Chapet O; Ramaioli A; Romestaing P
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):142-9. PubMed ID: 12182984
[TBL] [Abstract][Full Text] [Related]
17. Contact X-ray brachytherapy for rectal cancer: Past, present, and future.
Gérard JP; Barbet N; Dejean C; Montagne L; Bénézery K; Coquard R; Doyen J; Durand Labrunie J; Hannoun-Lévi JM
Cancer Radiother; 2021 Dec; 25(8):795-800. PubMed ID: 34052134
[TBL] [Abstract][Full Text] [Related]
18. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial.
Gerard JP; Chapet O; Nemoz C; Hartweig J; Romestaing P; Coquard R; Barbet N; Maingon P; Mahe M; Baulieux J; Partensky C; Papillon M; Glehen O; Crozet B; Grandjean JP; Adeleine P
J Clin Oncol; 2004 Jun; 22(12):2404-9. PubMed ID: 15197202
[TBL] [Abstract][Full Text] [Related]
19. Contact X-ray Brachytherapy as an Adjunct to a Watch and Wait Approach is an Affordable Alternative to Standard Surgical Management of Rectal Cancer for Patients with a Partial Clinical Response to Chemoradiotherapy.
Rao C; Stewart A; Martin AP; Collins B; Pritchard DM; Athanasiou T; Sun Myint A
Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):625-633. PubMed ID: 30196845
[TBL] [Abstract][Full Text] [Related]
20. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
